Managing inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may soon become more advanced and ...

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months ...

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months ...

Upadacitinib may offer superior disease management than tofacitinib for patients with ulcerative colitis. Learn more.

Bowel urgency is much more common during a UC flare, but people with inflammatory bowel disease (IBD) may also experience urgency while in remission. Bowel urgency is the sudden and unexpected ...

people with ulcerative colitis should still get regular care from a specialist healthcare provider (a gastroenterologist). Treatments that include everything from medications to lifestyle changes to ...

Mirikizumab treatment is safe and efficacious for ulcerative colitis up to 152 weeks in those with and without previous biologic therapy failure. Mirikizumab treatment for 152 weeks is associated ...

Mirikizumab treatment is safe and efficacious for ulcerative colitis up to 152 weeks in those with and without previous biologic therapy failure. Mirikizumab treatment for 152 weeks is associated with ...

While there’s no cure, medications like anti-inflammatories and corticosteroids can help manage symptoms, along with lifestyle changes around diet and avoiding food triggers. Lynch WD, Hsu R.

For the 907,000 Americans with ulcerative colitis, living with symptoms like urgent bowel movements, abdominal cramps, and loose or bloody stools can be overwhelming, but treatments can help keep ...

If your ulcerative colitis (UC) hasn’t responded well enough to treatment, your doctor may suggest surgery and an ostomy pouch. This might sound intimidating. But for people with certain birth ...